Navigation Links
Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions
Date:5/30/2008

CHICAGO, May 30 /PRNewswire/ -- Data from three observational studies reported at the American Society of Clinical Oncology (ASCO) Annual Meeting evaluated transfusion-related outcomes in cancer chemotherapy patients with various hemoglobin (Hb) levels prior to or during administration of erythropoiesis-stimulating agents (ESAs).

Two analyses were conducted using observational data from the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry. The first study (Larholt et al., abstract number 6637) reported that lower mean Hb levels achieved during ESA therapy were associated with increased transfusion requirements in cancer patients receiving chemotherapy. Another study of oncology patients who initiated ESA therapy at different baseline Hb levels (Burton et al., publication number 20637) concluded that blood utilization was greater when ESA therapy was initiated in patients who had baseline Hb of less than 10 grams per deciliter of blood (g/dL) compared with patients who received ESA therapy with a baseline Hb between 10 and 11 g/dL.

The third study (Gilmore, et al., abstract number 6548) examined hematologic outcomes in ESA-treated cancer chemotherapy patients with chemotherapy-induced anemia before and after implementation of the Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for ESAs. The results found lower Hb values and higher transfusion rates in patients covered by Medicare following adoption of the NCD guidelines for reimbursement for ESA therapies.

"As ESA coverage policies have become more restrictive, these findings are important in helping stakeholders understand the potential impact on transfusion patterns. The data demonstrated that when patients achieved lower mean hemoglobin levels during ESA therapy for chemotherapy-induced anemia, the need for transfusions increased," said Kay Larholt, Sc.D., Vice President, Biometrics, at Abt Bio-Pharma Solutions, Inc
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Genmab Announces Updates on Phase III Cancer Studies
4. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
5. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
6. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
7. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
8. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
9. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
10. New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
11. N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ), today announced ... Executive Officer, will preside over the NASDAQ Stock Market ... of Breast Cancer Awareness Month. In his remarks, Mr. ... important benefits of Hologic,s 3D Mammography technology, the only ... to traditional mammography. This is the ninth ...
(Date:9/30/2014)... -- This study provides an analysis of the ... nuclear imaging informatics, PET imaging informatics, and multimodality ... size of the market based on its historic ... growth based on the current drivers and restraints, ... the broader markets for imaging equipment, advanced visualization, ...
(Date:9/30/2014)... 30, 2014 Aileron Therapeutics, Inc. - ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - Product ... the Aileron Therapeutics, Inc.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Aileron Therapeutics, ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3
... 5th is a great day to quit smoking for good.  There are more ... 7,200 of them die from a tobacco-related illness.(1) As of July 5 , ... free law that took effect in all restaurants, bars and workplaces.(2) , ... Research shows that policy changes, like the new statewide smoke-free law, ...
... 6 Reportlinker.com announces that a new market research report is available ... Opportunities ... , , ... , , ...
Cached Medicine Technology:Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit 2Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit 3Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 2Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 3Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 4Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 5Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 6Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 7Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 8Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 9Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 10Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 11
(Date:10/1/2014)... Scientists at the University of Western ... immune system proteins has the power to knock out ... of the new study on their website. Click ... in the UWA School of Pathology and Laboratory Medicine ... with mesothelioma with promising results. , “A timed ...
(Date:10/1/2014)... October 01, 2014 Nordic Naturals ... a very special cause. The campaign—“Buy One Bottle. ... Paws for Veterans, a nonprofit organization that helps ... rescuing shelter dogs that would otherwise face euthanasia. ... products will support monthly donations of Nordic Naturals ...
(Date:10/1/2014)... October 01, 2014 Dr. Saj Jivraj, ... and prosthodontists, is traveling to Chennai, India, tomorrow to ... Oct. 2 and 3. , Dr. Jivraj is founder ... and Oxnard, Calif., and one of the world’s foremost ... and replacement. He is speaking to the Indian Society ...
(Date:10/1/2014)... Generic drug prices are on the ... price in the last 12 months. For its Sept. ... News (DBN) interviewed a plan sponsor and a financial ... health plans. , “When MAC [maximum allowable cost] ... these cost increases squeeze pharmacies’ profits,” explains Adam Fein, ...
(Date:10/1/2014)... This October, Request A Test , ... is offering 10% off all testing for Diabetes . ... order to save. The Center for Disease Control (CDC) ... affected by Diabetes. Because many people do not display ... it causes serious health problems. Blood testing can help ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 3Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 2Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 3
... Kathleen Doheny HealthDay Reporter , WEDNESDAY, Oct. ... States are less likely to breast-feed their babies than ... the bottle as the primary reason, new research finds. ... disparity between ethnic groups persists, said Dr. Amudha ...
... consensus statement published in the September, 2010, issue of ... Metabolism ( JCEM ) finds that the increasing ... than commonly believed suggests that regular glycemia screening, early ... aggressive intervention deserves greater emphasis. The consensus ...
... The Michael J. Fox Foundation for Parkinson,s Research announced ... studies and 14 pre-clinical therapeutic development projects. The funding ... under the Clinical Intervention Awards, one of the Foundation,s ... Grantees under the 2010 Clinical Intervention Awards are: ...
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) -- ... admit they are binge drinkers, health officials said Tuesday. ... four or more drinks for women, and five or more ... that are different because men and women metabolize alcohol differently. ...
... Cancer Care is hosting the 42nd Congress of the International ... in the world, SIOP is returning to the United States ... Thursday, Oct. 21, through Sunday, Oct. 24, 2010, Media room ... Saturday, and 8 a.m. to 3 p.m. Sunday. Location: ...
... plaque debris could trigger a "paradigm shift" in how physicians ... of Endovascular Today . "We will see a ... of Loyola University Health System and Dr. Aravinda Nanjundappa of ... patients, the device had a success rate of 97 percent ...
Cached Medicine News:Health News:Breast-Feeding Less Common for Black Moms 2Health News:Breast-Feeding Less Common for Black Moms 3Health News:Experts advocate realigning type 2 diabetes treatments with disease's natural history 2Health News:MJFF announces over $10 million in funding for clinical and pre-clinical PD research 2Health News:1 in 4 U.S. Teens and Young Adults Binge Drink: CDC 2Health News:1 in 4 U.S. Teens and Young Adults Binge Drink: CDC 3Health News:Boston, Oct. 21-24: Largest international pediatric oncology conference 2Health News:'Paradigm shift' in how physicians treat peripheral artery disease 2
0-3.5 LPM Oxygen Flowmeter with Ohmeda male inlet...
0-15 LPM Oxygen Flowmeter with Chemetron male inlet...
... Click style oxygen flowmeters., ... add suffix S to model ... Canadian Color-Code, add suffix C ... , For Double Flowmeters with ...
... Slim Line Flowmeters with brass ... For security chain, add suffix S ... For Canadian Color-Code, add suffix C ... For Double Flowmeters with Power Take-Off, ...
Medicine Products: